A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018-19 season: the Gripometro
Por:
Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J and Martinón-Torres F
Publicada:
25 abr 2022
Ahead of Print:
25 abr 2022
Categoría:
Public health, environmental and occupational health
Resumen:
AsbtractBackground Electronic vaccine registries are not yet widely established. There is a need to real-time monitor influenza vaccine coverage, which may raise awareness to risk groups and professionals, and eventually allow to adopt tailored measures during the vaccination campaign. To evaluate the utility of the "Gripometro", a demographic study designed to monitor national and regional influenza vaccine coverage on a weekly basis in Spain. Methods Quantitative study based on surveys of the Spanish population between 18-80 years and a sample of primary care doctors and nurses randomly selected. Pre-proportional fixation has been established by Autonomous Communities and age group to guarantee the representativeness of all the autonomies. Results Interviews were conducted in 3400 households of general population and 807 respondents among health care professionals. We found that the results of influenza vaccination coverage in the population >= 65 years obtained by the Gripometro for 2018-2019 season were mostly comparable with the official data presented by the Ministry of Health after the end of the vaccination campaign. Conclusions The Gripometro is a robust research method that provides real-time data and trends for influenza vaccine coverage along with other useful information related to vaccination such as intention to vaccinate, motivation and barriers to vaccination.
Filiaciones:
:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020, Valencia, Spain.
Redondo Margüello E:
Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, Spain
Ortiz de Lejarazu Leonardo R:
Centro Nacional de Gripe de Valladolid, Valladolid, Spain
Gil de Miguel Á:
Departamento de Especialidades Médicas y Salud Pública, Universidad Rey Juan Carlos, Madrid, Spain
Guillén Ortega JM:
Sanofi España, Madrid, Spain
Rincón Mora J:
Instituto Análisis e Investigación, Madrid, Spain
Martinón-Torres F:
Servicio de Pediatría, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
Grupo de Genética, Infecciones y Vacunas en Pediatría (GENVIP), Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain
gold, Green Submitted, Green Published
|